Christopher J. Storbeck

The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility

Simona Wagner, Christopher J. Storbeck, Paul G. O’Reilly et al. · Oncogene · 2009 · 50 citations

Breast Oncology, Signal Transduction, Signaling Pathway +11

Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity

Scott R. Walsh, Donald Bastin, Lan Chen et al. · Journal of Clinical Investigation · 2018 · 36 citations · Full text

Immunology, Immunoediting, Immunodominance +26

Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy

Adrian Pelin, Johann Foloppe, Julia Petryk et al. · Molecular Therapy — Oncolytics · 2019 · 32 citations · Full text

Cancer Therapy, Viral Replication, Apoptosis +24

Transient expression of Nxf, a bHLH–PAS transactivator induced by neuronal preconditioning, confers neuroprotection in cultured cells

Ian Hester, Sarah McKee, Phillip Pelletier et al. · Brain Research · 2007 · 28 citations

Cultured Cells, Bhlh–pas Transactivator, Transient Expression +13

Ste20‐like kinase SLK displays myofiber type specificity and is involved in C2C12 myoblast differentiation

Christopher J. Storbeck, Kate Daniel, Yihong Zhang et al. · Muscle & Nerve · 2004 · 21 citations